Antiplatelet Drugs in Ischemic Stroke Prevention: From Monotherapy to Combined Treatment

Publisher： Karger

E-ISSN： 1421-9786|17|1|74-80

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.17, Iss.1, 2003-12, pp. : 74-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Drugs for Ischemic Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 27, Iss. 1, 2009-04 ,pp. : 120-125

Karger

Access to resources Recommend Favorite

Antiplatelet Cilostazol Is Effective in the Prevention of Pneumonia in Ischemic Stroke Patients in the Chronic Stage

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 57-60

Karger

Access to resources Recommend Favorite

Usefulness of Antiplatelet Drugs in Ischaemic Stroke Prevention – Update on New Trials

By  

Cerebrovascular Diseases, Vol. 24, Iss. 1, 2007-11 ,pp. : 112-115

Karger

Access to resources Recommend Favorite

Secondary Stroke Prevention with Drugs: Single or Combined Therapy?

By  

Cerebrovascular Diseases, Vol. 9, Iss. 3, 1999-07 ,pp. : 24-28

Karger

Access to resources Recommend Favorite

Lipid-Lowering Drugs in Ischemic Stroke Prevention and Their Influence on Acute Stroke Outcome

By  

Cerebrovascular Diseases, Vol. 27, Iss. 1, 2009-04 ,pp. : 126-133

Karger

Access to resources Recommend Favorite